| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |